Drug Trial Radar · NCT00476996
A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)
Last checked: Nov 20, 2026Latest source record: Aug 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
836
Actual
Start
May 15, 2007
Primary completion
Jan 21, 2010
Study completion May 14, 2018
Sponsor
- Lead sponsor
- Genentech, Inc.Roche (Genentech) (RHHBY)
- Sponsor type
- Industry
- Collaborators
- Roche Pharma AG
- First posted
- May 22, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy and safety of ocrelizumab, compared with placebo, in patients with active rheumatoid arthritis who have an inadequate response to at least one anti-TNF-alpha therapy. Patients will be randomized to receive placebo, 200mg of intravenous ocrelizumab, or 500mg of i.v. ocrelizumab on days 1 and 15. A repeat course of i.v. treatment will be administered at weeks 24 and 26. All patients will receive stable doses of either concomitant methotrexate (7.5-25mg/week) or leflunomide (10-20mg po daily) and may receive additional DMARDs. The treatment period is planned for 48 weeks (until primary analysis) and then participants will enter the open label phase until the drug is commercialized. Target sample size is 1000.
Conditions
- Rheumatoid Arthritis
Interventions
LeflunomideDrug
Oral repeating dose
MethotrexateDrug
Oral or parenteral repeating dose
OcrelizumabDrug
Intravenous repeating dose (200mg)
OcrelizumabDrug
Intravenous repeating dose (500mg)
PlaceboDrug
Intravenous repeating dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With American College of Rheumatology 20 (ACR20) ResponsesTime frame: Weeks 24 and 48
Locations
266 sites in 25 countries. Site status is shown where the registry gives one.
Pinnacle Research Group; Llc, Central
Anniston, Alabama
Rheumatology Associates
Birmingham, Alabama
Rheumatology Associates of North Alabama
Huntsville, Alabama
Arizona Arthritis & Rheumatology Research, Pllc
Mesa, Arizona
Arthrocare, Arthritis Care and Research, P.C.
Mesa, Arizona
Catalina Pointe Clinical Research, Inc.
Tucson, Arizona
Uni of Arizona Health Science Center; Dept of Rheumatology/Immunology
Tucson, Arizona
CHI St. Vincent Medical Group Hot Springs
Hot Springs, Arkansas
Little Rock Diagnostic Clinic
Little Rock, Arkansas
Allergy & Rheumatology Centre
La Jolla, California
Private Practice
Long Beach, California
Valerius Medical Group & Research Ctr of Greater Long Beach
Los Alamitos, California
Uni of Southern California School of Medicine
Los Angeles, California
Pacific Arthritis Care Center
Los Angeles, California
Stanford Uni Medical Center; Divison of Rheumatology
Palo Alto, California
Ucsd, Dept of Medicine; Rheumatology
San Diego, California
San Diego Arthritis Med Clnc
San Diego, California
East Bay Rheumatology
San Leandro, California
Arthritis Treatment Center of South Bay
Torrance, California
University of Colorado Cancer Center
Aurora, Colorado
Arthritis Assoc & Osteoporosis; Ctr of Colorado Springs
Colorado Springs, Colorado
Arthritis & Osteoporosis Center P.C.
Camden, Connecticut
New England Research Associates
Trumbull, Connecticut
Rheumatolgy Consultants of Deleware
Lewes, Delaware
Javed Rheumatology Associates, Inc.
Newark, Delaware
Arthritis & Rheumatism; Disease Specialities
Aventura, Florida
Jacksonville Center For Clinical Research
Jacksonville, Florida
Arthritis Center Palm Harbor
Palm Harbor, Florida
Arthritis Rsrch of Florida, Inc.
Palm Harbor, Florida
Sarasota Arthritis Center; Research Dept
Sarasota, Florida
Center For Arthritis; Research Dept
South Miami, Florida
SW Florida Clinical Research
Tampa, Florida
Tampa General Hospital; Rheumatology Research Dept
Tampa, Florida
Burnette & Silverfield, MDS
Tampa, Florida
Florida Medical Center
Zephyrhills, Florida
Atlanta Center For Clinical Research.
Atlanta, Georgia
Csi Research, Inc.
Cumming, Georgia
Marietta Rheumatology Associates, Pc
Marietta, Georgia
Intermountain Orthopaedics
Boise, Idaho
Coeur D'Alene Arthritis Clinic
Coeur d'Alene, Idaho
Showing 40 of 266 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.